Increased in all-cause mortality. Anaphylaxis/anaphylactoid reactions; known hypersensitivity to tetracyclines. Monotherapy in patients w/ cIAI secondary to clinically apparent intestinal perforation. Pseudomembranous colitis; acute pancreatitis; hospital-acquired pneumonia; overgrowth of nonsusceptible organisms. May be associated w/ tooth discoloration. Monitor blood coagulation parameters prior to & during treatment. May affect ability to drive & use machines. Significant hepatic dysfunction & failure. Pregnancy & lactation. Not recommended in childn <18 yr.
Sign Out
 50 mg5c8a82d4-0896-4674-a26e-a428012f1623.GIF)
